CompletedNCT02413918
Iloperidone Added to Ongoing Treatment for Mixed Mood States in Bipolarity
About this title
Iloperidone in Mixed States of Bipolar Disorder
Read the official source — NCT02413918Medication studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- San AntonioSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 41
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT02413918
- Official title
Show the full official title
Open Label Study of Iloperidone (IL) as Adjunctive Treatment in Mixed States (MS) of Bipolar Disorder (BD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Antonio
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center at San Antonio, a university.
Did this study involve medication?
Yes. The study involved medication, including iloperidone.
Who was this study for?
Listed age limits: from 18 years.
